Shares in telehealth group Hims & Hers Health (NYSE:HIMS) dropped in premarket US trading on Thursday after federal drug ...

Weight-loss jabs will be rolled out across the NHS for the first time in an effort to tackle obesity. Health officials have ...

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

Eli Lilly & Co.’s blockbuster weight-loss and diabetes drugs are no longer considered to be in shortage in the US, threatening to upend the many knockoffs that became popular when ...

Bill Gates visiting TerraPower Isotopes, the subsidiary of the nuclear power company TerraPower that he helped found. Gates ...

The two-year shortage of Eli Lilly’s blockbuster weight-loss and diabetes drugs is over, the U.S. Food and Drug ...

The search for more affordable medications might cause people to access dangerous counterfeit drugs sold as genuine products ...

INDIANAPOLIS - Eli Lilly and Company announced Wednesday that it will invest $4.5 billion to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development in ...

The company’s first two investments in the district were for a manufacturing site. The new site will focus on research, but ...

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

FOX59's Claire Curry visited one of Indy's busiest roadways on Wednesday and got updates on ongoing construction projects.

Lilly officials said a newly-announced facility near Lebanon could shorten the drug research and development cycle by up to a year or more.